COMP <GO>
DTM vs CVX // NET PROFIT MARGIN
DT Midstream Inc. Common Stock (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: DTM 8
— CVX 7
▲ NET PROFIT MARGIN LEADER: DTM
LAST: $124.34 (-2.08%) • MKT CAP: $12.95B
net-margins
35.50%
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
net-margins
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DTM VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DTM | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.30% | -0.30 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.10% | 5.80% | +0.30 | DTM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.6x | 21.5x | -4.90 | DTM | /valuation <GO> |
| Free Cash Flow Yield | 3.40% | 5.61% | -2.21 | CVX | /fcf-yield <GO> |
| Operating Margin | 49.40% | 8.10% | +41.30 | DTM | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 35.50% | 6.70% | +28.80 | DTM | /net-margins <GO> |
| Revenue Growth (YoY) | 26.70% | -4.60% | +31.30 | DTM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.50% | 2.79% | -0.29 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.94 | 3.71 | -1.77 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | DTM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.10% | -0.40 | DTM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 72.8 | -23.95 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.07 | -0.14 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.7x | 34.6x | -9.90 | DTM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.95B | $457.31B | -$444.36B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DTM REV | CVX REV | DTM GROSS % | CVX GROSS % | DTM FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.24B | $184.43B | 44.0% | 41.3% | $441.0M | $25.64B |
| FY 2024 | $981.0M | $193.41B | 44.0% | 38.4% | $413.0M | $22.79B |
| FY 2023 | $922.0M | $196.91B | 44.0% | 44.0% | $756.5M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DTM // BETA 0.93
CVX // BETA 1.07